Visalytics
Visalytics
approved EB-2 (NIW)

Graduate Assistant

Pharmaceutical Science · India · 2022-05-16

Processing Time
154 days
Decision Date
2022-05-16
Location
Iowa
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to analyze and characterize cocrystals and amorphous solids to enhance aqueous solubility and improve physical drug characteristics. This work aims to support pharmaceutical product development and improve drug properties for conditions such as cancer and Raynaud’s phenomenon.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor improves critical properties of pharmaceutical products, supporting public health and the success of the pharmaceutical industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of experience, 14 total publications, and has conducted 39 peer reviews for journals in her field.

3 Waiver of Job Offer and Labor Certification Met

The broad applicability of her advancements in drug solubility and the significance of the global pharmaceutical market justify a waiver.

Why This Petition Was Approved

The petition was approved based on the client's 8 years of experience, 13 peer-reviewed journal articles, and 1 first-authored book chapter. Her work garnered 140 citations and she completed 39 peer reviews, demonstrating her influence and that she met all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Chemist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
New Jersey 47 days 2025-07-30
The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Texas 7 days 2024-02-21
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing cancer therapy through the development of polymeric drugs. Her work involves sophisticated investigations into novel drug delivery systems designed to increase treatment efficacy while reducing toxicity for conditions like cancer and Inflammatory Bowel Disease (IBD).
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-05-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 154 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist